HRT Financial’s DexCom DXCM Stock Holding History

HRT Financial’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$433K	Sell	6,900 -20,200	-75%	-$1.41M	﹤0.01%	2635
2025 Q4	$1.8M	Buy	27,100 +17,100	+171%	+$1.11M	0.01%	1375
2025 Q3	$672K	Buy	+10,000	New	+$791K	﹤0.01%	1727

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HRT Financial's DXCM Position: Q1 2026 in Review

HRT Financial sold out of DexCom (DXCM) in Q1 2026, closing a stake of 3,810 shares — an estimated $265K sold.

HRT Financial first reported a position in DXCM in Q3 2018 and held it in 14 quarters. The position peaked at $22.3M in Q4 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

HRT Financial reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
HRT Financial sold 3,810 DexCom shares in Q1 2026, an estimated $265K.
HRT Financial first reported a position in DexCom in Q3 2018 and held it in 14 quarters.
HRT Financial's DexCom position peaked at $22.3M in Q4 2024.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.